亨迪药业(301211.SZ)：盐酸甲氧氯普胺获得化学原料药上市申请批准通知书

Core Viewpoint - Hendi Pharmaceutical has received approval from the National Medical Products Administration for the marketing application of Methoclopramide Hydrochloride, a dopamine receptor antagonist used to alleviate nausea and vomiting symptoms, as well as to promote gastrointestinal motility to improve dyspepsia and delayed gastric emptying [1] Company Summary - Hendi Pharmaceutical (301211.SZ) has recently announced the approval of its application for Methoclopramide Hydrochloride [1] - The drug is primarily indicated for the relief of nausea and vomiting [1] - Additionally, it can aid in enhancing gastrointestinal motility, addressing issues such as dyspepsia and delayed gastric emptying [1]